The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation

Author： Burnett Allison Tiongson Jay Downey Ross Mahan Charles E

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.9, 2013-06, pp. : 1119-1133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticoagulation for Non‐Valvular Atrial Fibrillation in Older People

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 3, 2012-09 ,pp. : 228-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticoagulant Use, the Prevalence of Bridging, and Relation to Length of Stay among Hospitalized Patients with Non-Valvular Atrial Fibrillation

By Smoyer-Tomic Karen

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 6, 2012-12 ,pp. : 403-413

Adis International

Access to resources Recommend Favorite

Anticoagulation Therapy for Patients with Non-Valvular Atrial Fibrillation: Comparison of Decision Analytic Model Recommendations and Real-World Warfarin Prescription Use

By Casciano Julian P.

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 313-323

Adis International

Access to resources Recommend Favorite

Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Optimal Intensity of Anticoagulation

By Yasaka M. Yamaguchi T.

CNS Drugs, Vol. 15, Iss. 8, 2001-01 ,pp. : 623-631

Adis International

Access to resources Recommend Favorite

Stroke Prevention in Patients with Non-valvular Atrial Fibrillation: New Insight in Selection of Rhythm or Rate Control Therapy and Impact of Mean Platelet Volume

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5824-5829

Bentham Science Publishers

Access to resources Recommend Favorite